WASP Antikörper (AA 145-265) (HRP)
Kurzübersicht für WASP Antikörper (AA 145-265) (HRP) (ABIN7175829)
Target
Alle WASP (WAS) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 145-265
-
Verwendungszweck
- WAS Antibody, HRP conjugated
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant Human Wiskott-Aldrich syndrome protein (145-265AA)
-
Isotyp
- IgG
-
-
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 57-170) antibody
WAS Reaktivität: Human ELISA, IHC, FACS Wirt: Maus Monoclonal 7B10E4 unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 39-251) antibodyWAS Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (Internal Region) antibodyVerified WAS Reaktivität: Human ELISA, IHC, FACS, IF Wirt: Ziege Polyclonal unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 145-265) antibodyWAS Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 116-144) antibodyWAS Reaktivität: Human, Maus WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB23643 unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (Internal Region) antibodyWAS Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 129-156), (C-Term) antibodyWAS Reaktivität: Human, Maus, Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 60-250) antibodyWAS Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 205-234) antibodyWAS Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB40707 unconjugated
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 122-152), (Middle Region) antibodyWAS Reaktivität: Human, Maus WB, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- WASP (WAS) (Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))
-
Andere Bezeichnung
- WAS
-
Hintergrund
-
Background: Effector protein for Rho-type GTPases. Regulates actin filament reorganization via its interaction with the Arp2/3 complex. Important for efficient actin polymerization. Possible regulator of lymphocyte and platelet function. Mediates actin filament reorganization and the formation of actin pedestals upon infection by pathogenic bacteria.
Aliases: Eczema thrombocytopenia antibody, IMD2 antibody, SCNX antibody, THC antibody, THC1 antibody, Thrombocytopenia 1 (X linked) antibody, U42471 antibody, Was antibody, WASp antibody, WASP_HUMAN antibody, Wiskott Aldrich syndrome (eczema thrombocytopenia) antibody, Wiskott Aldrich syndrome antibody, Wiskott Aldrich syndrome protein antibody, Wiskott-Aldrich syndrome protein antibody
-
UniProt
- P42768
Target
-
